Angina and myocardial infarctions Flashcards

1
Q

What is stable angina often referred to?

A

‘Exercise-induced’ angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the clinical presentations of stable angina?

A

Ischaemic chest pain caused by atherosclerotic plaques that cause narrowing of the lumen diameter of the arteries and reducing blood supply to the heart muscles. Meaning the oxygen demand can’t be met during periods of increased demand:
The chest pain becomes critical at a point of certain oxygen demand from the heart so usually presents itself when:
- Exercising
- Stressed
- After heavy meals
- In the presence of extreme temperatures

This chest pain is relieved by periods of rest, as the demand from the heart is decreased again
Also by use of sublingual glyceryl trinitrate (in tablet or spray form)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How can the chest pain caused by stable angina be reduced?

A
  • Periods of rest- reducing the oxygen demand by the heart
  • Sublingual GTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the symptoms of stable angina?

A

Central, crushing chest pain
Pain may radiate to jaw, neck back or arms
is relieved by rest or GTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the treatment guidelines/management options for stable angina?

A

FOR ACUTE ATTACKS:
- All patients should be given sublingual (under the tongue) Glyceryl trinitrate in the form of tablets or a spray

FIRST LINE TREATMENT:
- Anti-anginals- used to prevent attacks in the first place
1st line = Beta blockers or Calcium channel blockers

Add-on= long-acting nitrates e.g. Isosorbide mononitrate, Ivabradine, Ranolazine or Nicorandil

Secondary prevention- Prevent worsening of symptoms or cardiac events
Lifestyle changes;
smoking cessation
weight loss
diet
exercise

  • Anti-platelet- Aspirin 75mg OD
  • Statins- Atorvastatin 20-80mg OD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What conditions are covered in the umbrella term of Acute coronary syndrome?

A

Myocardial infarctions
- ST elevated (STEMI)
- Non-ST elevated (NSTEMI)
AND
- Unstable angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which three factors are used to differential diagnose between the three components of Acute coronary syndrome and other conditions?

A
  • History of ischaemic chest pain- check is not gastro-related pain e.g. indigestion
  • ECG changes
  • Increased release in cardiac enzymes in blood tests results
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the typical ECG abnormality in a patient who has had a STEMI?

A
  • An elevation in the ST segment of the ECG trace

this is not seen in an NSTEMI or unstable angina!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the relevance of cardiac enzyme levels in differential diagnoses of ACS?

A

Troponin I (the more common isomer of the two) and Troponin T are enzymes that are released in the presence of cardiac muscle damage.
After a myocardial infarction, these enzymes after 2-4 hours, they will peak at 12 hours and can persist for up to 7 days ( beneficial for non-immediate diagnoses)

Levels will be measured on admission to hospital AND 3 hours later

If the increase in Troponin levels have increased to more than the 99th Percentile, they are indicative of a STEMI or NSTEMI

In unstable angina, there may be slight changes in levels, but nowhere near this 99 percentile increase criteria

other enzymes are also increased in the presence of a STEMI/NSTEMI but are not used for diagnosis due to lack of specificity
- Creatine kinase
- Aspartate transaminase (AST)
- lactate dehydrogenase (LDH)

Note that troponin levels can also be increased in other conditions e.g.:
pulmonary embolism
heart failure
chronic kidney disease
myocarditis
sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between a STEMI and a NSTEMI? (look for more detail online!!!!)

A

STEMI- the damage to the full thickness of cardiac muscle ( the whole depth= WORSE)
NSTEMI- Damage to partial thickness of cardiac muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clinical features/ symptoms of NSTEMI/STEMI?

A
  • Severe chest pain- sudden, constant, even at rest
  • Not received by rest or sublingual GTN
  • Sweating
  • Breathlessness
  • N+V
  • Restlessness
  • Pale/grey appearance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the symptoms and clinical manifestations of unstable angina?

A
  • Sudden deterioration in anginal symptoms
  • Chest pain- not relieved by rest or S/L GTN
  • No ECG changes or changes in troponin levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the immediate treatment steps for a STEMI?

A
  • Oxygen- only if indicated- an oxygen saturation below 90%
  • Diamorphine- used for pain relief (opioid).
    However, also has other beneficial effects:
    Anxiolytic effects- patients after MI are likely to be anxious
    Vasodilatory- increased blood flow
  • Anti-emetic (anti-sickness), as opioid analgesics often cause N+V e.g. Cyclizine, Metoclopramide
  • Aspirin- STAT dose of 300mg (may have already been administered prior to admission e.g. by paramedic or GP)
  • A second anti-platelet
    e.g. 300mg STAT clopidogrel
    180mg STAT Ticagrelor
    60mg STAT Prasugrel

AND primary percutaneous coronary intervention (PPCI)- This is the first line of management for a STEMI as has better outcomes and fewer contraindications than thrombolysis:

  • Have an angiogram to assess where the blockage is, the causative clot is then removed by sucking it out with a radio-peque tube. Then a stent or angioplasty will be continued.

OR Thrombolysis:
- Breaks down the clot and reperfuses the area to minimise damage- Activates plasminogen to be concerted to the active form of plasmin. Plasmin then breaks down the fibrin network in the clot.
e.g. Alteplase, Recteplase, Tenecteplase
- need to give heparin for first 48 hours after thrombolysis- to prevent further clot formation

both thrombolysis and PPCI need to be done URGENTLY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the treatment for secondary prevention following a STEMI (+ their durations)?

A

NEED FIVE DRUGS!

1+2: DUAL-ANTIPLATELET THERAPY
1. Aspirin
2. Clopidogrel or Ticagrelor or Prasugrel
dual-therapy for 12 months and then stop clopidogrel/ticagrelor/prasugrel
Aspirin continued for life

3: BETA-BLOCKER- review after 12 months, it may be stopped ( if have heart failure will definitely be continued)

4: ACE-INHIBITOR- for life

5: STATIN- Atorvastatin 80mg OD

AND lifestyle changes:
- Smoking cessation
- Weight loss
- Improve diet to be more balanced and healthy
- Increased exercise and physical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the immediate treatment steps for a NSTEMI or presentation of unstable angina?

A

THESE STEPS ARE THE SAME AS THAT OF A STEMI (+ Fondaparinux) and (- thrombolysis or ppci):

  • Oxygen- only if indicated- an oxygen saturation below 90%
  • Diamorphine- used for pain relief (opioid).
    However, also has other beneficial effects:
    Anxiolytic effects- patients after MI are likely to be anxious
    Vasodilatory- increased blood flow
  • Anti-emetic (anti-sickness), as opioid analgesics often cause N+V e.g. Cyclizine, Metoclopramide
  • Aspirin- STAT dose of 300mg (may have already been administered prior to admission e.g. by paramedic or GP)
  • A second anti-platelet
    e.g. 300mg STAT clopidogrel
    180mg STAT Ticagrelor
    60mg STAT Prasugrel

AND give Fondaparinux- A factor Xa inhibitor that prevents the formation of any new blood clots
Given via an injection until stable

NO thrombolysis or PPCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the treatment for secondary prevention following a NSTEMI/Unstable angina (+ their durations)?

A

Dependent of 6-month prediction- risk of further cardiovascular event and mortality.
Assessed using GRACE scale:
- If risk >3% would give PPCI (primary percutaneous coronary intervention)
- if risk <3% no PPCI, conservative management

NEED FIVE DRUGS!

1+2: DUAL-ANTIPLATELET THERAPY
1. Aspirin
2. Clopidogrel or Ticagrelor or Prasugrel
dual-therapy for 12 months and then stop clopidogrel/ticagrelor/prasugrel
Aspirin continued for life

3: BETA-BLOCKER- review after 12 months, it may be stopped ( if have heart failure will definitely be continued)

4: ACE-INHIBITOR- for life

5: STATIN- Atorvastatin 80mg OD

AND lifestyle changes:
- Smoking cessation
- Weight loss
- Improve diet to be more balanced and healthy
- Increased exercise and physical activity

17
Q

What is the process of an angiogram?

A
  • A thin radiopaque tube is inserted into the coronary circulation- either via blood vessels in the wrist or the femoral vein (groin)
  • X-RAY contrast media is added into the tube (add colour contrast)- allows proffessionals to see where the x-ray contrast accumulates due to a blockage- decreased blood flow
18
Q

What are the surgical interventions following a MI/angina?

A
  • Percutaneous coronary intervention- angioplasty or stenting
  • Coronary artery by-pass grant (CABG) - ‘Open heart surgery’

PCI; causative clot Is removed through sucking divide added to the radiopaque tube that sucks out the clot. Then stunting or angioplasty is commenced:

  • ANGIOPLASTY:
    A deflated balloon is mounted on to a catheter and inserted via a radio-paque tube
    This is pushed through any stenosis and inflated. Inflation, pushes any atherosclerotic material to the wall of the artery- opening of the narrowing
  • Balloon is then deflated, and removed- blood flows restores
  • HOWEVER, over time restenosis can occur ( plaque reforms and re-blocks the artery)

Prevention of restenosis- STENT:
- Wire mesh with a balloon inside is pushed through the stenosis
- As the balloon is inflated, it expands the wire mesh and holds the arteries open

2 types of stent:
- Bare metal stent- overtime can undergo endothelialisation- becomes grown into the endothelium = restenosis
- Drug- eluting stents- stent carries anti-proliferative drugs (e.g. Tacrolimus, Paclitaxel) and releases it over time- slows down endothelialisation

Drug-eluting balloon- balloon covered in paclitaxel is released into the vessel- the drug is lipophilic so is absorbed into the artery wall- prevents restenosis.
However, is not as effective as stents but is useful is patient is at risk of in-stent thrombosis

  • Coronary artery by-pass surgery (CABG)
    open heart surgery- if stenosis is so severe that stents or balloons can’t be pushed through
  • Vessels are taken from the leg and grafted to either side of the stenosis. Often an internal mammary artery from the chest will be used as htis best mimics the coronary arteries.
    can bypass up to 4 affected blood vessels
    requires specialist hospitals e.g. Papworth
19
Q

What are the contra-indications + side effects of thrombolysis?

A

Complications:
- Previous cerebral vascular accident (CVA) - stroke
- Recent surgery
- Peptic ulcer
- Uncontrolled hypertension
- >6 hours since onset of symptoms

Side effects:
Haemorrhage
CVA
Reperfusion arrythmias
allergies- Streptokinase is a drug that can be used in thrombolysis- it has a different MOA to the other drugs as is antigenic- can only have 1 dose

  • need to give heparin for first 48 hours after thrombolysis- to prevent further clot formation
20
Q

What other drug therapy is recommended in conjunction with dual anti-platelet therapy (DAPT)?

A
  • PPIs should be prescribed in patients on dual-antiplatelet therapy as both aspirin and clopidogrel increase risk of GI ulceration and bleeding.
  • It is usually recommended for 1 year and then reviewed- may be reduced to PRN
  • Recommendations are Lansoprazole over omeprazole or esoemeprazole. This is because omeprazole significantly decreases the efficacy of clopidogrel as it competitively inhibits the CYP2C19 isoenzyme that metabolises clopidogrel to its active form and therefore decreasing the ability of clopidogrel to reduce platelet aggregation.
21
Q

What PPI is recommended for co-prescribing with dual anti platelet therapies and why?

A

-Recommendations are Lansoprazole over omeprazole or esoemeprazole.

This is because omeprazole significantly decreases the efficacy of clopidogrel as it competitively inhibits the CYP2C19 isoenzyme that metabolises clopidogrel to its active form and therefore decreasing the ability of clopidogrel to reduce platelet aggregation.

22
Q

Why is metformin held in patients who have had a myocardial infarction?

A

Metformin is stopped as it is cautioned in conditions that cause tissue hypoxia:

This occurs in MI- lack of oxygen supply to the heart which can cause lactic acidosis. Is a very rare side effect of metformin.

Also, in PPCI, x-ray contrast media (iodine-containing) can cause AKI (renal impairment). AKI can also lead to an increased risk of lactic acidosis.

23
Q

In diabetic patients who have had a myocardial infarction (now have established CVD) or a QRISK score above 10%, what drug should they be on?

A

An SGLT-2 inhibitor e.g. Dapagliflozin

  • Note if the patient is not on SGLT2, it should be recommended on discharge to be reviewed by a GP and start after discharge. This is because, SGLT2 inhibitors have a risk of DKA. Therefore, it should not be given to hospitalised patients or those that are acutely unwell (if patient is already on sglt2, it should be held)
24
Q

If a patient is feeling dizzy while taking the medications prescribed for secondary prevention of CHD, what can be recommended?

A

Take Ramipril in the evening and beta blocker in the morning
- Splitting beta blocker and ace inhibitor up to prevent over reduction in blood pressure= hypotension, can cause falls and dizziness